Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing’s Disease in Spain

This article belongs to the Special Issue From Hyperfunction to Insufficiency: A Comprehensive Look at Adrenal Disorders.

Bibliographic Details
Authors:	Araujo-Castro, Marta, García-Centeno, Rogelio, González, Laura, Hanzu, Felicia Alexandra, Orois, Aida, Camara, Rosa, Ollero García, M. Dolores, Irigaray Echarri, Ana, Gracia Gimeno, Paola, Pascual-Corrales, Eider, Biagetti, Betina, Cardona, Andrés, González-Molero, Inmaculada, Simó-Servat, Andreu, Guerrero-Pérez, Fernando, Villar-Taibo, Rocío, Bernabéu, Ignacio, Fajardo-Montañana, Carmen, Novo-Rodríguez, Cristina, Tenorio-Jiménez, Carmen, Calatayud, María, Moure Rodríguez, María Dolores, Cordido, Fernando, Castro, Ana, Manzano Valero, Lucía, Paja-Fano, Miguel, Goi, Jessica, Aulinas, Anna, Abellán, Pablo, Iglesias, Pedro, Soto-Moreno, Alfonso
Format:	article
Status:	Published version
Publication Date:	2025
Country:	España
Institution:	Consejo Superior de Investigaciones Científicas (CSIC)
Repository:	DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:	oai:digital.csic.es:10261/413140
Online Access:	http://hdl.handle.net/10261/413140 https://api.elsevier.com/content/abstract/scopus_id/105021537353
Access Level:	Open access
Keyword:	Cushing’s disease Cushing’s syndrome Osilodrostat Pituitary Urinary free cortisol

Description
Summary:	This article belongs to the Special Issue From Hyperfunction to Insufficiency: A Comprehensive Look at Adrenal Disorders.